新国都(300130) - 2021 Q3 - 季度财报

Financial Performance - The company's operating revenue for Q3 2021 reached ¥963,941,402.12, an increase of 51.58% compared to the same period last year[4] - The net profit attributable to shareholders for Q3 2021 was ¥62,554,237.26, up 47.90% year-on-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥42,282,492.43, reflecting a 12.70% increase compared to the previous year[4] - The company reported a 40.37% increase in total operating revenue for the first nine months of 2021, totaling ¥2,574,847,564.97[10] - The company achieved an operating revenue of approximately ¥2.575 billion for the first three quarters, marking a year-over-year growth of 40.37%[18] - The gross profit for the same period was approximately ¥569 million, reflecting a 16.78% increase year-over-year[18] - The net profit attributable to shareholders was ¥156 million, with a year-over-year growth of 13% when excluding the impact of year-end bonuses[18] - Total operating revenue for the third quarter of 2021 reached ¥2,574,847,564.97, an increase of 40.4% compared to ¥1,834,274,966.03 in the same period of 2020[28] Assets and Liabilities - Total assets as of the end of Q3 2021 amounted to ¥3,730,248,315.03, representing a 10.49% increase from the end of the previous year[4] - The company's total liabilities increased significantly, with accounts payable rising to ¥353,520,485.85, a 50.74% increase year-on-year[10] - The company's total assets as of September 30, 2021, were ¥3,730,248,315.03, compared to ¥3,376,142,629.91 at the end of 2020, representing a growth of 10.5%[27] - The total liabilities increased to ¥1,236,997,811.28, compared to ¥949,716,641.26 in the previous year, reflecting a rise of 30.3%[27] - The company's equity attributable to shareholders reached ¥2,476,339,413.14, an increase from ¥2,426,729,873.74, showing a growth of 2.0%[27] Cash Flow - The company's cash flow from operating activities for the year-to-date was ¥81,941,523.80, down 50.43% compared to the same period last year[4] - The company reported a net cash flow from operating activities of ¥81,941,523.80, a decrease of 50.43% compared to the previous period due to increased expenses related to procurement and business subsidies[13] - The net cash flow from investing activities was -¥38,068,247.58, a decline of 124.00% year-over-year, primarily due to the absence of significant cash inflows from the disposal of subsidiary equity[13] - The net increase in cash and cash equivalents was -¥116,883,315.96, representing a 174.98% decrease, attributed to reduced cash inflows from subsidiary disposals and increased procurement expenses[13] - The total cash inflow from operating activities is 2,999,669,769.48, an increase from 2,024,817,804.87, showing a growth of about 48.2%[38] - Cash outflow from operating activities totals 2,917,728,245.68, compared to 1,859,498,408.90 in the previous period, which is an increase of approximately 56.8%[38] - The net cash flow from operating activities is 81,941,523.80, down from 165,319,395.97, indicating a decrease of about 50.5%[38] - The cash inflow from investment activities is 581,412,470.83, compared to 404,024,442.30 in the previous period, representing an increase of approximately 43.8%[38] - The cash outflow from investment activities is 619,480,718.41, up from 245,396,177.51, indicating a significant increase of about 152.1%[38] Research and Development - Research and development expenses for the year-to-date reached ¥183,239,694.24, a 36.22% increase compared to the same period last year[10] - Research and development expenses increased to ¥183,239,694.24, compared to ¥134,521,716.58 in the previous year, marking a rise of 36.2%[28] - The company invested significantly in new product development, launching the "Medical Insurance Business Comprehensive Service Terminal" which has passed certification[18] - Research and sales expenses increased by approximately ¥48.72 million and ¥41.07 million, representing year-over-year growth of 36% and 39% respectively[18] Market and Strategic Initiatives - The subsidiary JiaLian Payment processed a transaction volume of approximately ¥1.348 trillion, a 52% increase year-over-year, with operating revenue growth of about 41%[18] - The company plans to explore new opportunities in the electronic payment industry leveraging AI and big data technologies[18] Profitability and Margins - The company reported a net profit margin improvement, with net profit for the period expected to increase due to higher revenue and controlled costs[28] - The net profit for the current period is 156,072,585.91, a decrease from 166,224,566.97 in the previous period, representing a decline of approximately 6.9%[31] - The total profit for the current period is 163,958,341.65, down from 178,407,362.67, indicating a decrease of about 8.6%[31] - Operating profit for the current period is 164,878,485.44, compared to 189,632,493.93 in the previous period, reflecting a decline of approximately 13.1%[31] Cash and Equivalents - The cash and cash equivalents decreased to ¥1,513,939,449.99 from ¥1,596,431,665.33, a decline of 5.2%[24] - The cash and cash equivalents at the end of the period decreased to $1.24 billion from $1.36 billion at the beginning of the period, reflecting a net decrease of $116.88 million[41] Compliance and Standards - The company adopted the new leasing standards starting January 1, 2021, which resulted in adjustments to the financial statements without affecting retained earnings[48] - The company reported a total of $64.09 million in adjustments related to the new leasing standards, impacting both assets and liabilities[48] Receivables - The company maintained a stable level of receivables, with accounts receivable at approximately $403.11 million[42] Product Development and Market Expansion - The company has not disclosed any new product developments or market expansion strategies in the current report[50]